Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

58 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
High-throughput screening identifies broad-spectrum Coronavirus entry inhibitors.
Khan S, Partuk EO, Chiaravalli J, Kozer N, Shurrush KA, Elbaz-Alon Y, Scher N, Giraud E, Tran-Rajau J, Agou F, Barr HM, Avinoam O. Khan S, et al. Among authors: agou f. iScience. 2024 May 17;27(6):110019. doi: 10.1016/j.isci.2024.110019. eCollection 2024 Jun 21. iScience. 2024. PMID: 38883823 Free PMC article.
A highly sensitive cell-based luciferase assay for high-throughput automated screening of SARS-CoV-2 nsp5/3CLpro inhibitors.
Chen KY, Krischuns T, Ortega Varga L, Harigua-Souiai E, Paisant S, Zettor A, Chiaravalli J, Courtney D, O'Brien A, Baker SC, Isel C, Agou F, Jacob Y, Blondel A, Naffakh N. Chen KY, et al. Among authors: agou f. bioRxiv [Preprint]. 2021 Dec 21:2021.12.18.473303. doi: 10.1101/2021.12.18.473303. bioRxiv. 2021. Update in: Antiviral Res. 2022 May;201:105272. doi: 10.1016/j.antiviral.2022.105272 PMID: 34981051 Free PMC article. Updated. Preprint.
PvDBPII elicits multiple antibody-mediated mechanisms that reduce growth in a Plasmodium vivax challenge trial.
Martinez FJ, White M, Guillotte-Blisnick M, Huon C, Boucharlat A, Agou F, England P, Popovici J, Hou MM, Silk SE, Barrett JR, Nielsen CM, Reimer JM, Mukherjee P, Chauhan VS, Minassian AM, Draper SJ, Chitnis CE. Martinez FJ, et al. Among authors: agou f. NPJ Vaccines. 2024 Jan 6;9(1):10. doi: 10.1038/s41541-023-00796-7. NPJ Vaccines. 2024. PMID: 38184681 Free PMC article.
Effective Inhibition of TDP-43 Aggregation by Native State Stabilization.
Yang L, Jasiqi Y, Zettor A, Vadas O, Chiaravalli J, Agou F, Lashuel HA. Yang L, et al. Among authors: agou f. Angew Chem Int Ed Engl. 2024 Jan 15;63(3):e202314587. doi: 10.1002/anie.202314587. Epub 2023 Dec 11. Angew Chem Int Ed Engl. 2024. PMID: 37949836 Free article.
Design and synthesis of naturally-inspired SARS-CoV-2 inhibitors.
Hassan H, Chiavaralli J, Hassan A, Bedda L, Krischuns T, Chen KY, Li ASM, Delpal A, Decroly E, Vedadi M, Naffakh N, Agou F, Mallart S, Arafa RK, Arimondo PB. Hassan H, et al. Among authors: agou f. RSC Med Chem. 2023 Jan 25;14(3):507-519. doi: 10.1039/d2md00149g. eCollection 2023 Mar 22. RSC Med Chem. 2023. PMID: 36970153 Free PMC article.
Potent human broadly SARS-CoV-2-neutralizing IgA and IgG antibodies effective against Omicron BA.1 and BA.2.
Planchais C, Fernández I, Bruel T, de Melo GD, Prot M, Beretta M, Guardado-Calvo P, Dufloo J, Molinos-Albert LM, Backovic M, Chiaravalli J, Giraud E, Vesin B, Conquet L, Grzelak L, Planas D, Staropoli I, Guivel-Benhassine F, Hieu T, Boullé M, Cervantes-Gonzalez M, Ungeheuer MN, Charneau P, van der Werf S, Agou F; French COVID Cohort Study Group; CORSER Study Group; Dimitrov JD, Simon-Lorière E, Bourhy H, Montagutelli X, Rey FA, Schwartz O, Mouquet H. Planchais C, et al. Among authors: agou f. J Exp Med. 2022 Jul 4;219(7):e20220638. doi: 10.1084/jem.20220638. Epub 2022 Jun 15. J Exp Med. 2022. PMID: 35704748 Free PMC article.
58 results